In vivo exposure to a new 2‐cyano‐2‐p‐nitrophenyl‐N‐benzylthioamide decreases doxorubicin‐triggered structural damages in the mature testis
Sign Up to like & getrecommendations! Published in 2022 at "Andrologia"
DOI: 10.1111/and.14634
Abstract: The use of doxorubicin (DOX) in clinical practice continues to be challenged by its severe toxicity. DOX cytotoxic activity is not only directed against malignant tumours, given that the treatment will damage healthy tissues as… read more here.
Keywords: cell; dox; exposure new; testis ... See more keywords